贫困国家的耐药感染：机会之窗不断缩小。
Drug Resistant Infections in Poor Countries: A shrinking window of opportunity.
作者信息
Gonzales Ralph, Corbett Kitty K, Wirtz Veronika, Dreser Anahi
机构信息
Clinical and Translational Sciences Institute KL2 Multidisciplinary Career Development Program, University of California, San Francisco, USA.
出版信息
BMJ. 2008 Apr 26;336(7650):948-9. doi: 10.1136/bmj.39534.553044.94. Epub 2008 Apr 8.
Abstract
Resistance to drugs in many common childhood infections is a growing problem in the developing world, says (doi: 10.1136/bmj.39520.680718.94). Effective programmes to combat resistance are within reach in developing countries, argue , but we must move swiftly
摘要
（doi: 10.1136/bmj.39520.680718.94）称，在发展中世界，许多常见儿童感染对药物产生耐药性是一个日益严重的问题。 等人认为，发展中国家有能力实施有效的抗耐药性方案，但我们必须迅速行动。
相似文献
1
Drug Resistant Infections in Poor Countries: A shrinking window of opportunity.
BMJ. 2008 Apr 26;336(7650):948-9. doi: 10.1136/bmj.39534.553044.94. Epub 2008 Apr 8.
2
Global health actors claim to support health system strengthening: is this reality or rhetoric?
PLoS Med. 2009 Apr 28;6(4):e1000059. doi: 10.1371/journal.pmed.1000059.
3
The impact of genomics on global health.
Am J Public Health. 2002 Jul;92(7):1077-9. doi: 10.2105/ajph.92.7.1077.
4
Antibiotic resistance in developing countries.
J Chemother. 2001 Apr;13 Suppl 1:40-4. doi: 10.1080/1120009x.2001.11782327.
5
Oral health policies in developing countries.
J Public Health Policy. 2010 Dec;31(4):498-9. doi: 10.1057/jphp.2010.31.
6
Resistance to antimicrobial drugs--a worldwide calamity.
Ann Intern Med. 1993 Apr 1;118(7):557-61. doi: 10.7326/0003-4819-118-7-199304010-00011.
7
Debating the quality and performance of health systems at a global level is not enough, national debates are essential for progress.
Trop Med Int Health. 2008 Apr;13(4):444-7. doi: 10.1111/j.1365-3156.2008.02073.x. Epub 2008 Mar 13.
8
Quality of care in developing countries: relevance and reality.
Qual Health Care. 1997 Dec;6(4):179-80. doi: 10.1136/qshc.6.4.179.
9
Chronic diseases in developing countries.
Lancet. 2007 Dec 22;370(9605):2076-8. doi: 10.1016/S0140-6736(07)61877-7.
10
Antimicrobial resistance in the age of noncommunicable diseases.
Rev Panam Salud Publica. 2011 Dec;30(6):515-8.
引用本文的文献
1
Antibiotic identification, use, and self-medication for respiratory illnesses among urban Latinos.
J Am Acad Nurse Pract. 2010 Sep;22(9):488-95. doi: 10.1111/j.1745-7599.2010.00539.x.
本文引用的文献
1
The role of poverty in antimicrobial resistance.
J Am Board Fam Med. 2007 Nov-Dec;20(6):533-9. doi: 10.3122/jabfm.2007.06.070019.
2
Evidence-based quality improvement: the state of the science.
Health Aff (Millwood). 2005 Jan-Feb;24(1):138-50. doi: 10.1377/hlthaff.24.1.138.
3
A view on antimicrobial resistance in developing countries and responsible risk factors.
Int J Antimicrob Agents. 2004 Aug;24(2):105-10. doi: 10.1016/j.ijantimicag.2004.02.015.
4
[Impact of regulatory measures in the trends of community consumption of antibiotics in Chile].
Rev Med Chil. 2002 Nov;130(11):1265-72.
5
Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics.
Ann Intern Med. 2000 Jul 18;133(2):128-35. doi: 10.7326/0003-4819-133-2-200007180-00012.
6
Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries.
Emerg Infect Dis. 1999 Jan-Feb;5(1):18-27. doi: 10.3201/eid0501.990103.
7
Antimicrobial resistance in developing countries.
BMJ. 1998 Sep 5;317(7159):647-50. doi: 10.1136/bmj.317.7159.647.
Zotero 插件